Published in BMC Med on December 06, 2011
A novel urine peptide biomarker-based algorithm for the prognosis of necrotising enterocolitis in human infants. Gut (2013) 1.62
Point-of-care differentiation of Kawasaki disease from other febrile illnesses. J Pediatr (2012) 1.55
Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease. EMBO Mol Med (2012) 1.05
Building a Natural Language Processing Tool to Identify Patients With High Clinical Suspicion for Kawasaki Disease from Emergency Department Notes. Acad Emerg Med (2016) 0.89
Peptidomic Identification of Serum Peptides Diagnosing Preeclampsia. PLoS One (2013) 0.83
Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients. Int J Mol Sci (2016) 0.80
Periostin is upregulated in coronary arteriopathy in Kawasaki disease and is a potential diagnostic biomarker. Pediatr Infect Dis J (2014) 0.78
Kawasaki disease: a matter of innate immunity. Clin Exp Immunol (2016) 0.77
Pediatric Kawasaki Disease and Adult Human Immunodeficiency Virus Kawasaki-Like Syndrome Are Likely the Same Malady. Open Forum Infect Dis (2016) 0.76
A Classification Tool for Differentiation of Kawasaki Disease from Other Febrile Illnesses. J Pediatr (2016) 0.76
Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses. PLoS One (2016) 0.75
Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker. Int J Mol Sci (2017) 0.75
A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease. PLoS One (2016) 0.75
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem (1993) 27.24
ROCR: visualizing classifier performance in R. Bioinformatics (2005) 19.60
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
Cell type-specific gene expression differences in complex tissues. Nat Methods (2010) 4.75
Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest (2006) 4.37
Urine in clinical proteomics. Mol Cell Proteomics (2008) 2.05
Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol (2010) 2.00
Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol (2007) 1.39
Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J Orthop Res (2008) 1.36
CORNA: testing gene lists for regulation by microRNAs. Bioinformatics (2009) 1.21
Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler Thromb Vasc Biol (2003) 1.11
Kawasaki Disease update. Indian J Pediatr (2009) 1.10
Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin Exp Immunol (2005) 1.07
Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states. Clin Immunol (2009) 1.05
Retracted Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation (2001) 1.02
Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. J Infect Dis (2009) 0.99
Urine peptidomics for clinical biomarker discovery. Adv Clin Chem (2010) 0.99
The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child (2006) 0.94
Circulating soluble selectins in Kawasaki disease. Clin Exp Immunol (1997) 0.94
Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis. Clin Proteomics (2010) 0.93
Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease. Pediatr Infect Dis J (2001) 0.91
Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis. Pediatr Int (1999) 0.88
The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease. Clin Exp Immunol (2007) 0.87
[Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease]. Zhonghua Er Ke Za Zhi (2005) 0.86
Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr (2002) 0.86
Kawasaki disease: 40 years after the original report. Curr Rheumatol Rep (2007) 0.86
Decreased protein binding of salicylates in Kawasaki disease. J Pediatr (1991) 0.84
Expression of CD180, a toll-like receptor homologue, is up-regulated in children with Kawasaki disease. J Mol Med (Berl) (2005) 0.83
Microarrays: new tools for transplantation research. Pediatr Nephrol (2003) 0.81
Kawasaki disease: a 'new' pediatric enigma. Hosp Pract (1978) 0.80
How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med (2007) 5.86
Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med (2009) 5.68
Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis. JAMA (2007) 2.91
Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol (2003) 2.88
Cytokines and cognition--the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc (2002) 2.79
Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol (2003) 2.77
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet (2007) 2.77
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood (2006) 2.62
Developing a cancer-specific geriatric assessment: a feasibility study. Cancer (2005) 2.57
A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet (2009) 2.45
Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr (2008) 2.44
Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol (2005) 2.34
Perspectives, preferences, care practices, and outcomes among older and middle-aged patients with late-stage cancer. J Clin Oncol (2004) 2.14
Report of the national institute on aging task force on comorbidity. J Gerontol A Biol Sci Med Sci (2007) 2.06
Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol (2010) 2.00
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet (2011) 1.97
Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther (2008) 1.95
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia. Pediatr Blood Cancer (2010) 1.91
When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. J Am Coll Cardiol (2009) 1.88
Lifestyle intervention development study to improve physical function in older adults with cancer: outcomes from Project LEAD. J Clin Oncol (2006) 1.84
Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia. Circulation (2012) 1.82
Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis. Pediatrics (2008) 1.78
The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A (2013) 1.78
What is driving hospitals' patient-safety efforts? Health Aff (Millwood) (2004) 1.68
A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet (2012) 1.58
Does U.S. hospital capacity need to be expanded? Health Aff (Millwood) (2003) 1.58
Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele. Cytotherapy (2012) 1.55
Point-of-care differentiation of Kawasaki disease from other febrile illnesses. J Pediatr (2012) 1.55
Physical activity as a preventative factor for frailty: the health, aging, and body composition study. J Gerontol A Biol Sci Med Sci (2009) 1.55
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol (2010) 1.52
Low plasma D-dimer concentration predicts the absence of traumatic brain injury in children. J Trauma (2010) 1.50
Walking speed predicts health status and hospital costs for frail elderly male veterans. J Rehabil Res Dev (2005) 1.48
Impressions of Kawasaki syndrome in India. Indian Pediatr (2006) 1.47
Hospital staff and family perspectives regarding quality of pediatric palliative care. Pediatrics (2004) 1.47
Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet (2010) 1.45
Hemangioma of the umbilical cord with pseudocyst. Fetal Pediatr Pathol (2011) 1.45
Multiclass cancer classification and biomarker discovery using GA-based algorithms. Bioinformatics (2005) 1.45
Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors. Cancer (2009) 1.44
An overview of variance inflation factors for sample-size calculation. Eval Health Prof (2003) 1.44
Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol (2007) 1.39
Association of Kawasaki disease with tropospheric wind patterns. Sci Rep (2011) 1.38
Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol (2007) 1.37
The effect of geriatrics evaluation and management on nursing home use and health care costs: results from a randomized trial. Med Care (2006) 1.37
Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur J Biochem (2002) 1.37
Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. J Pediatr (2010) 1.34
Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics (2010) 1.33
Leading the Way in Exercise and Diet (Project LEAD): intervening to improve function among older breast and prostate cancer survivors. Control Clin Trials (2003) 1.29
A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice. Blood (2004) 1.26
Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass. J Biol Chem (2001) 1.26
FDR made easy in differential feature discovery and correlation analyses. Bioinformatics (2009) 1.24
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane. J Clin Oncol (2008) 1.24
Frailty thy name is ... Phrailty? J Gerontol A Biol Sci Med Sci (2007) 1.22
AKI in hospitalized children: epidemiology and clinical associations in a national cohort. Clin J Am Soc Nephrol (2013) 1.22
Kawasaki disease: late cardiovascular sequelae. Curr Opin Cardiol (2012) 1.21
Extracellular glutathione peroxidase (Gpx3) binds specifically to basement membranes of mouse renal cortex tubule cells. Am J Physiol Renal Physiol (2009) 1.17
Recognition of a Kawasaki disease shock syndrome. Pediatrics (2009) 1.17
Failure to diagnose Kawasaki disease at the extremes of the pediatric age range. Pediatr Infect Dis J (2004) 1.17
The combined effect of visual impairment and cognitive impairment on disability in older people. J Am Geriatr Soc (2007) 1.16
Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period. Intern Med (2011) 1.16
Geriatric Oncology Research in the Cooperative Groups: A Report of a SIOG Special Meeting. J Geriatr Oncol (2010) 1.13
Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol (2002) 1.12
Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. Autoimmunity (2010) 1.12
Differential expression of miR-145 in children with Kawasaki disease. PLoS One (2013) 1.12
Intracellular mediators of granulysin-induced cell death. J Immunol (2003) 1.11
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium. Eur J Cancer (2011) 1.10
DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA. Carcinogenesis (2012) 1.10
Physical function and associations with diet and exercise: Results of a cross-sectional survey among elders with breast or prostate cancer. Int J Behav Nutr Phys Act (2004) 1.09
Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer (2010) 1.09
Randomized controlled trial of ultrasound-guided peripheral intravenous catheter placement versus traditional techniques in difficult-access pediatric patients. Pediatr Emerg Care (2009) 1.09
Black-white disparity in disability: the role of medical conditions. J Am Geriatr Soc (2011) 1.08
The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis. J Neuroimmunol (2010) 1.07
Ibuprofen provides analgesia equivalent to acetaminophen-codeine in the treatment of acute pain in children with extremity injuries: a randomized clinical trial. Acad Emerg Med (2009) 1.07
Biological, clinical, and psychosocial correlates at the interface of cancer and aging research. J Natl Cancer Inst (2012) 1.07
Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01. J Clin Oncol (2002) 1.07
Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome. Pediatr Infect Dis J (2007) 1.07
Extracellular glutathione peroxidase is secreted basolaterally by human renal proximal tubule cells. Am J Physiol Renal Physiol (2002) 1.06
miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem Biophys Res Commun (2010) 1.06
Spatial and temporal clustering of Kawasaki syndrome cases. Pediatr Infect Dis J (2008) 1.05
Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol (2013) 1.05
Transcriptome analysis of stem development in the tumourous stem mustard Brassica juncea var. tumida Tsen et Lee by RNA sequencing. BMC Plant Biol (2012) 1.05
Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. J Clin Oncol (2014) 1.04